{"id":290613,"date":"2023-05-10T14:44:46","date_gmt":"2023-05-10T19:44:46","guid":{"rendered":"https:\/\/www.liveaction.org\/news\/?p=290613"},"modified":"2024-09-20T12:10:32","modified_gmt":"2024-09-20T17:10:32","slug":"mifepristone-miscarriage-cushing-syndrome","status":"publish","type":"post","link":"https:\/\/archive.liveaction.org\/news\/mifepristone-miscarriage-cushing-syndrome\/","title":{"rendered":"FACT CHECK: Will restricting the abortion pill impact treatment for miscarriage or Cushing syndrome?"},"content":{"rendered":"
<\/div>

Abortion proponents\u00a0claim<\/a>\u00a0that if access to the abortion pill (mifepristone) is limited, women who suffer from a miscarriage or from Cushing syndrome will be negatively impacted. But is this true?<\/p>\n

Mifepristone is the active ingredient used in both the abortion pill (brand name Mifeprex) and a separate drug called Korlym, which treats Cushing syndrome<\/a>. But while both drugs contain the same active ingredient, they have different dosages, different U.S. Food and Drug Administration (FDA) approvals, different uses, and different manufacturers.<\/p>\n

Since the Supreme Court overturned the Roe v. Wade<\/em> decision in the Dobbs v. Jackson Women’s Health Organization<\/em>\u00a0ruling in June 2022, state lawmakers have moved to restrict the abortion pill and prohibit the mailing of the drug. In addition, litigation challenging the 2000 FDA approval of mifepristone for abortion is ongoing<\/a> and will soon to be heard by the Fifth Circuit Court of Appeals, causing concerns that the drug could be made unavailable.<\/p>\n

\"Image:

Mifepristone Mifeprex (200 mg) and GenbioPro generic abortion pill versus Korlym (mifepristone 300 mg)<\/p><\/div>\n

What drug treats Cushing syndrome?<\/strong><\/p>\n

Korlym,\u00a0manufactured<\/a> by Corcept\u00a0Therapeutics, was approved in 2012 by the FDA to treat Cushing syndrome. It contains mifepristone as the active ingredient. According to the FDA’s approval letter<\/a>, Korlym’s mifepristone tablets are 300 milligrams versus the mifepristone approved by the FDA for the termination of pregnancy (abortion), which is 200 milligrams.<\/p>\n

Korlym\u2019s November 2019<\/a>\u00a0black box label<\/a> warns, “Mifepristone has potent antiprogestational effects and will result in the termination of pregnancy. Pregnancy must therefore be excluded before the initiation of treatment with KORLYM, or if treatment is interrupted for more than 14 days in females of reproductive potential.”<\/p>\n

What drug is known as the abortion pill?<\/strong><\/p>\n

The abortion pill was approved in 2000 as mifepristone (brand name Mifeprex) and is administered in a 200-milligram dosage. It is manufactured under the direction of\u00a0Danco Laboratories<\/a> and the generic version under\u00a0GenBioPro<\/a>.<\/p>\n

\u00a0